1. Home
  2. LSTA vs STKH Comparison

LSTA vs STKH Comparison

Compare LSTA & STKH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LSTA
  • STKH
  • Stock Information
  • Founded
  • LSTA 1980
  • STKH 2018
  • Country
  • LSTA United States
  • STKH Israel
  • Employees
  • LSTA N/A
  • STKH N/A
  • Industry
  • LSTA Misc Health and Biotechnology Services
  • STKH Packaged Foods
  • Sector
  • LSTA Health Care
  • STKH Consumer Staples
  • Exchange
  • LSTA Nasdaq
  • STKH Nasdaq
  • Market Cap
  • LSTA 20.9M
  • STKH 21.6M
  • IPO Year
  • LSTA N/A
  • STKH 2021
  • Fundamental
  • Price
  • LSTA $2.52
  • STKH $3.75
  • Analyst Decision
  • LSTA Strong Buy
  • STKH
  • Analyst Count
  • LSTA 2
  • STKH 0
  • Target Price
  • LSTA $23.50
  • STKH N/A
  • AVG Volume (30 Days)
  • LSTA 23.5K
  • STKH 1.6M
  • Earning Date
  • LSTA 11-11-2025
  • STKH 11-21-2025
  • Dividend Yield
  • LSTA N/A
  • STKH N/A
  • EPS Growth
  • LSTA N/A
  • STKH N/A
  • EPS
  • LSTA N/A
  • STKH N/A
  • Revenue
  • LSTA $1,070,000.00
  • STKH $10,000.00
  • Revenue This Year
  • LSTA N/A
  • STKH N/A
  • Revenue Next Year
  • LSTA N/A
  • STKH N/A
  • P/E Ratio
  • LSTA N/A
  • STKH N/A
  • Revenue Growth
  • LSTA N/A
  • STKH N/A
  • 52 Week Low
  • LSTA $1.87
  • STKH $3.56
  • 52 Week High
  • LSTA $4.20
  • STKH $132.00
  • Technical
  • Relative Strength Index (RSI)
  • LSTA 54.15
  • STKH 49.36
  • Support Level
  • LSTA $2.36
  • STKH $4.20
  • Resistance Level
  • LSTA $2.62
  • STKH $4.53
  • Average True Range (ATR)
  • LSTA 0.18
  • STKH 0.53
  • MACD
  • LSTA 0.03
  • STKH -0.25
  • Stochastic Oscillator
  • LSTA 72.08
  • STKH 6.45

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.

About STKH Steakholder Foods Ltd.

Steakholder Foods Ltd is engaged in transforming the alternative protein industries through its technology. The group specializes in developing and selling 3D-printing production machines, supported by proprietary premix blends, formulated from the highest-quality raw ingredients. These tools help manufacturers of all sizes efficiently produce foods that meet consumer expectations for taste, texture, and appearance and offer a safe and sustainable alternative to industrialized meat and seafood production. The company's expertise in creating alternative protein products replicating traditional meats' complex textures such as beef steaks, white fish, shrimp, and eel. It also explores the integration of cultivated cells, preparing for future advancements in food technology.

Share on Social Networks: